Regulations.gov document
Acknowledgment Letter from FDA DMS to Gland Pharma Limited
Other · FDA-2021-P-0339 · posted Apr 13, 2021
Key facts
| Document ID | FDA-2021-P-0339-0002 |
|---|---|
| Title | Acknowledgment Letter from FDA DMS to Gland Pharma Limited |
| Document type | Other |
| Subtype | Acknowledgement Letter/Receipt |
| Agency | FDA |
| Docket | FDA-2021-P-0339 |
| Posted | Apr 13, 2021 |
| Comment period opens | Apr 13, 2021 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: